TGFB1 and pancreatic neoplasm: In addition, genistein dose-dependently efficiently inhibits transforming growth factor beta1 (TGF-β1)-induced invasion and metastatic potential of human pancreatic cancer in vitro by downregulating MMP-2 and uPA expression [84].